Resting Heart Rate: Risk Indicator and Emerging Risk Factor in Cardiovascular Disease

Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.

McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)

Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879

Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study

Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., & McKinlay, J. B. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)34871-1 · Cited by 5,074

2013 ESC guidelines on the management of stable coronary artery disease

Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510

European guidelines on cardiovascular disease prevention in clinical practice: executive summary

Graham, I., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,865

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61198-1 · Cited by 2,563

ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary article

Gibbons, R. J., Abrams, J., Chatterjee, K., Daley, J., DEEDWANIA, P. C., Douglas, J. S., Ferguson, T. B., Fihn, S. D., Fraker, T. D., Gardin, J. M., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02848-6 · Cited by 1,685

Untitled work

Graham (2007) · doi:10.1097/01.hjr.0000277983.23934.c9 · Cited by 1,647

Role of Endothelial Shear Stress in the Natural History of Coronary Atherosclerosis and Vascular Remodeling

Chatzizisis, Y. S., Coskun, A. U., Jonas, M., Edelman, E. R., Feldman, C. L., & Stone, P. H. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.059 · Cited by 1,483

Heart rate and cardiovascular mortality: The Framingham study

Kannel, W. B., Kannel, C., Paffenbarger, R. S., & Cupples, L. A. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90666-1 · Cited by 1,292

Pathophysiology of Progressive Nephropathies

Remuzzi, G., & Bertani, T. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811123392007 · Cited by 1,258

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

Böhm, M., Swedberg, K. B., Michel Komajda, N., BORER, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61259-7 · Cited by 1,100

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

Fox, K., Ford, I., Steg, P. G., Tendera, M., & Ferrari, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61170-8 · Cited by 1,099

Hyperpolarization-Activated Cation Channels: From Genes to Function

Biel, M., Wahl‐Schott, C., Michalakis, S., & Zong, X. (2009) · Physiological Reviews · doi:10.1152/physrev.00029.2008 · Cited by 1,035

The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies

Hostetter, T. H., Rennke, H. G., & Brenner, B. M. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90490-9 · Cited by 800

Effect of Heart Rate Control With Esmolol on Hemodynamic and Clinical Outcomes in Patients With Septic Shock

Morelli, A., Ertmer, C., Westphal, M., Rehberg, S. W., Kampmeier, T., Ligges, S., Orecchioni, A., D’Egidio, A., D''Ippoliti, F., Raffone, C., et al. (2013) · JAMA · doi:10.1001/jama.2013.278477 · Cited by 739

Altered myocardial force-frequency relation in human heart failure.

Mulieri, L. A., Hasenfuss, G. P., Leavitt, B. J., Allen, P. D., & Alpert, N. R. (1992) · Circulation · doi:10.1161/01.cir.85.5.1743 · Cited by 597

How does adrenaline accelerate the heart?

Brown, H. F., DiFrancesco, D., & Noble, S. J. (1979) · Nature · doi:10.1038/280235a0 · Cited by 585

HEART RATE AS A PROGNOSTIC FACTOR FOR CORONARY HEART DISEASE AND MORTALITY: FINDINGS IN THREE CHICAGO EPIDEMIOLOGIC STUDIES

Dyer, A. R., Persky, V., Stamler, J., Paul, O., Shekelle, R. B., Berkson, D. M., Lepper, M. M., Schoenberger, J. A., & Lindberg, H. A. (1980) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113046 · Cited by 553

Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial

Lechat, P. P., Hulot, J., Escolano, S., Mallet, A., Leizorovicz, A., Werhlen-Grandjean, M., Pochmalicki, G., & Dargie, H. (2001) · Circulation · doi:10.1161/01.cir.103.10.1428 · Cited by 526

Sympathetic Overstimulation During Critical Illness: Adverse Effects of Adrenergic Stress

Dünser, M. W., & Hasibeder, W. R. (2009) · Journal of Intensive Care Medicine · doi:10.1177/0885066609340519 · Cited by 495

Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure

Fox, K., Ford, I., Steg, P. G., Tardif, J.-C., Tendera, M., & Ferrari, R. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406430 · Cited by 486

Meta-analysis: β-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure

McAlister, F. A., Wiebe, N., Ezekowitz, J. A., Leung, A. A., & Armstrong, P. W. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00006 · Cited by 481

Antianginal and Antiischemic Effects of Ivabradine, an I f Inhibitor, in Stable Angina

BORER, J. S., Fox, K. M., Jaillon, P., & Lerebours, G. (2003) · Circulation · doi:10.1161/01.cir.0000048143.25023.87 · Cited by 474

Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction

van Veldhuisen, D. J., Solal, A. C., Böhm, M., Anker, S. D., Babalis, D. S., Roughton, M., Coats, A. J. S., Poole-Wilson, P. A., & Flather, M. D. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.046 · Cited by 468

ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Gibbons, R. (2003) · Journal of the American College of Cardiology · Cited by 445

Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator

Solomon, H., Man, J. W., & Jackson, G. (2003) · Heart · doi:10.1136/heart.89.3.251 · Cited by 436

β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease

Bangalore, S., Steg, G., Deedwania, P., Crowley, K., Eagle, K. A., Goto, S., Ohman, E. M., Cannon, C. P., Smith, S. C., Zeymer, U., et al. (2012) · JAMA · doi:10.1001/jama.2012.12559 · Cited by 436

Heart Rate Lowering by Specific and Selective If Current Inhibition with Ivabradine

DiFrancesco, D., & Camm, A. J. (2004) · Drugs · doi:10.2165/00003495-200464160-00003 · Cited by 411

Assessing Cardiorespiratory Fitness Without Performing Exercise Testing

Jurča, R., Jackson, A. S., LaMonte, M. J., Morrow, J. R., Blair, S. N., Wareham, N. J., Haskell, W. L., van Mechelen, W., Church, T. S., Jakicic, J. M., et al. (2005) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2005.06.004 · Cited by 405

Retarding effect of lowered heart rate on coronary atherosclerosis.

Beere, P., Glagov, S., & Zarins, C. K. (1984) · Science · doi:10.1126/science.6484569 · Cited by 403

Pulse rate, coronary heart disease, and death: The NHANES I Epidemiologic Follow-up Study

Gillum, R. F., Makuc, D. M., & Feldman, J. J. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90970-s · Cited by 402

Left Ventricular Muscle Mass and Elevated Heart Rate Are Associated With Coronary Plaque Disruption

Heidland, U. E., & Strauer, B. E. (2001) · Circulation · doi:10.1161/hc3801.096325 · Cited by 348

Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial

Tardif, J., Ponikowski, P. P., Kahan, T., & for the ASSOCIATE study Investigators (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn571 · Cited by 338

Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy

Conway, M. A., Allis, J. L., Ouwerkerk, R., Niioka, T., Rajagopalan, B., & Radda, G. K. (1991) · The Lancet · doi:10.1016/0140-6736(91)91838-l · Cited by 318

Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy

Tardif, J.-C., O'Meara, E., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Tavazzi, L., & Swedberg, K. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr311 · Cited by 300

Long-Term Heart Rate Reduction Induced by the Selective I f Current Inhibitor Ivabradine Improves Left Ventricular Function and Intrinsic Myocardial Structure in Congestive Heart Failure

Mulder, P. G. H., Barbier, S., Chagraoui, A., Richard, V. J., Henry, J., Lallemand, F., Renet, S., Lerebours, G., Mahlberg‐Gaudin, F., & Thuillez, C. (2004) · Circulation · doi:10.1161/01.cir.0000118464.48959.1c · Cited by 294

Predictive Value of Clinic and Ambulatory Heart Rate for Mortality in Elderly Subjects With Systolic Hypertension

Palatini, P. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.20.2313 · Cited by 289

Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms

Loutzenhiser, R., Griffin, K. A., Williamson, G. A., & BIDANI, A. K. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00402.2005 · Cited by 280

Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice

Laufs, U., Gertz, K. R., Dirnagl, U., Böhm, M., Nickenig, G., & Endres, M. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02649-5 · Cited by 279

Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups*

Schmidt, H., Müller‐Werdan, U., Hoffmann, T., Francis, D. P., Piepoli, M. F., Rauchhaus, M., Prondzinsky, R., Loppnow, H., Buerke, M., Hoyer, D., et al. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000178181.91250.99 · Cited by 278

Influence of heart rate on mortality after acute myocardial infarction

Hjalmarson, Å. C., Gilpin, E. A., Kjekshus, J., Schieman, G., NICOD, P. H., Henning, H., & ROSS, J. R. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91029-6 · Cited by 275

Tachycardia-induced cardiomyopathy

Umaña, E., Solares, C. A., & Alpert, M. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01472-9 · Cited by 274

Heart Rate Reduction by Ivabradine Reduces Oxidative Stress, Improves Endothelial Function, and Prevents Atherosclerosis in Apolipoprotein E–Deficient Mice

Custodis, F., Baumhäkel, M., Schlimmer, N., List, F., Gensch, C., Böhm, M., & Laufs, U. (2008) · Circulation · doi:10.1161/circulationaha.107.746537 · Cited by 269

Effects on Outcomes of Heart Rate Reduction by Ivabradine in Patients With Congestive Heart Failure: Is There an Influence of Beta-Blocker Dose?

Swedberg, K. B., Michel Komajda, N., Böhm, M., BORER, J. S., Robertson, M., Tavazzi, L., & Ford, I. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.020 · Cited by 262

Renal Myogenic Response

Loutzenhiser, R., BIDANI, A. K., & Chilton, L. (2002) · Circulation Research · doi:10.1161/01.res.0000024262.11534.18 · Cited by 261

Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study

Böhm, M., Borer, J., Ford, I., Gonzalez-Juanatey, J. R., Komajda, M., Lopez-Sendon, J., Reil, J.-C., Swedberg, K., & Tavazzi, L. (2013) · Clinical Research in Cardiology · doi:10.1007/s00392-012-0467-8 · Cited by 248

Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents

Heusch, G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707673 · Cited by 246

Vascular Pathophysiology in Response to Increased Heart Rate

Custodis, F., Schirmer, S. H., Baumhäkel, M., Heusch, G., Böhm, M., & Laufs, U. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.014 · Cited by 242

Elevated heart rate and atherosclerosis: An overview of the pathogenetic mechanisms

Giannoglou, G. D., Chatzizisis, Y. S., Zamboulis, C., Parcharidis, G. E., Mikhailidis, D. P., & Louridas, G. E. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.08.077 · Cited by 235

Influence of the force—frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy

Hasenfuss, G. P., Holubarsch, C., Hermann, H., Astheimer, K., Pleske, B., & Just, H. (1994) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060471 · Cited by 230

Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial

Fox, K. M., Ford, I., Steg, P. G., Tendera, M., Robertson, M., Ferrari, R., & on behalf of the BEAUTIFUL Investigators (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp358 · Cited by 223

Erectile Dysfunction Predicts Coronary Heart Disease in Type 2 Diabetes

Ronald, C. W., So, W., Yang, X., Yu, L. W. L., Kong, A. P. S., Ko, G. T.-C., Chow, C., Cockram, C. S., Chan, J. C. N., & Tong, P. C.-Y. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.051 · Cited by 217

Analysis of Randomized Controlled Trials on the Effect of Magnitude of Heart Rate Reduction on Clinical Outcomes in Patients With Systolic Chronic Heart Failure Receiving Beta-Blockers

Flannery, G., Gehrig-Mills, R., Billah, B., & Krum, H. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.11.023 · Cited by 211

Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study

Ekman, I., Chassany, O., Michel Komajda, N., Böhm, M., BORER, J. S., Ford, I., Tavazzi, L., & Swedberg, K. B. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr343 · Cited by 206

Transient tachycardia; prognostic significance alone and in association with transient hypertension.

Levy, R. L., & WHITE, P. D. (1946) · PubMed · Cited by 195

Antianginal Efficacy and Safety of Ivabradine Compared with Amlodipine in Patients with Stable Effort Angina Pectoris

Rużyłło, W., Tendera, M., Ford, I., & Fox, K. M. (2007) · Drugs · doi:10.2165/00003495-200767030-00005 · Cited by 192

Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both

Böhm, M., Baumhäkel, M., Teo, K. K., Sleight, P., Probstfield, J. L., Gao, P., Mann, J. F. E., Díaz, R., Dagenais, G. R., Jennings, G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.864199 · Cited by 192

Cardiovascular risk factors: when should we treat?

Tonkin, A. M., Lim, S. S., & Schirmer, H. (2003) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05092.x · Cited by 186

Effect of If-Channel Inhibition on Hemodynamic Status and Exercise Tolerance in Heart Failure With Preserved Ejection Fraction

Kosmala, W., Holland, D. J., Rojek, A., Wright, L. M., Przewłocka‐Kosmala, M., & Marwick, T. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.06.043 · Cited by 183

Psychological distress, major depressive disorder, and risk of stroke

Surtees, P. G., Wainwright, N. W. J., Luben, R. N., Wareham, N. J., Bingham, S. A., & Khaw, K.-T. (2008) · Neurology · doi:10.1212/01.wnl.0000304109.18563.81 · Cited by 183

Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure

Castagno, D., Skali, H., Takeuchi, M., Swedberg, K. B., Yusuf, S., Granger, C. B., Michelson, E. L., Pfeffer, M. A., McMurray, J. J. V., & Solomon, S. D. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.12.044 · Cited by 173

Infusion of the β-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats*

Suzuki, T., Morisaki, H., Serita, R., Yamamoto, M., Kotake, Y., Ishizaka, A., & Takeda, J. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000182796.11329.3b · Cited by 170

Minimum heart rate and coronary atherosclerosis: Independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age

Perski, A., Olsson, G., Landou, C., Fairé, U. D., Theorell, T., & Hamsten, A. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90497-j · Cited by 166

Vagus nerve stimulation in experimental heart failure

Sabbah, H. N., Ilsar, I., Zaretsky, A., Rastogi, S., Wang, M., & Gupta, R. C. (2010) · Heart Failure Reviews · doi:10.1007/s10741-010-9209-z · Cited by 161

Clinical Efficacy of Ivabradine in Patients With Inappropriate Sinus Tachycardia

Cappato, R., Castelvecchio, S., Ricci, C., Bianco, E., Vitali-Serdoz, L., Gnecchi-Ruscone, T., Pittalis, M., De Ambroggi, L., Baruscotti, M., Gaeta, M., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.031 · Cited by 159

Cardioprotection, attenuated systemic inflammation, and survival benefit of β1-adrenoceptor blockade in severe sepsis in rats*

Ackland, G. L., Yao, S. T., Rudiger, A., Dyson, A., Stidwill, R. P., Poputnikov, D. M., Singer, M., & Gourine, A. V. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c03dfa · Cited by 155

TRANSIENT TACHYCARDIA

Levy, R. L. (1945) · JAMA · doi:10.1001/jama.1945.02860430001001 · Cited by 155

Resting heart rate is a predictor of mortality in COPD

Jensen, M. T., Marott, J. L., Lange, P., Vestbo, J., Schnohr, P., Nielsen, O. W., Jensen, J. S., & Jensen, G. B. (2012) · European Respiratory Journal · doi:10.1183/09031936.00072212 · Cited by 152

Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND

Lonn, E., Rambihar, S., Gao, P., Custodis, F., Sliwa, K. S., Teo, K. K., Yusuf, S., & Böhm, M. (2013) · Clinical Research in Cardiology · doi:10.1007/s00392-013-0644-4 · Cited by 148

Higher Heart Rate May Predispose to Obesity and Diabetes Mellitus: 20-Year Prospective Study in a General Population

Shigetoh, Y., Adachi, H., Yamagishi, S., Enomoto, M., Fukami, A., Otsuka, M., Kumagae, S., Furuki, K., Nanjo, Y., & Imaizumi, T. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2008.331 · Cited by 146

Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study

BORER, J. S., Böhm, M., Ford, I., Michel Komajda, N., Tavazzi, L., Sendon, J. L., Alings, M., de Sá, E. L., Swedberg, K. B., & on behalf of the SHIFT Investigators (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs259 · Cited by 144

Effect of Graded Heart Rate Reduction with Ivabradine on Myocardial Oxygen Consumption and Diastolic Time in Exercising Dogs

Colin, P., Ghaleh, B., Monnet, X., Hittinger, L., & Berdeaux, A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.059717 · Cited by 144

Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction

Heusch, G., Skyschally, A., Gres, P., van Caster, P., Schilawa, D., & Schulz, R. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn337 · Cited by 134

Resting Heart Rate Pattern During Follow-Up and Mortality in Hypertensive Patients

Paul, L. J., Hastie, C. E., Li, W. S., Harrow, C., Muir, S. W., Connell, J., Dominiczak, A. F., McInnes, G. T., & Padmanabhan, S. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.144808 · Cited by 134

Hemodynamic stress and experimental aortoiliac atherosclerosis

Bassiouny, H. S., Zarins, C. K., Kadowaki, M. H., & Glagov, S. (1994) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(94)70069-9 · Cited by 131

Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction

Reil, J., Hohl, M., Reil, G., Granzier, H. L. M., Kratz, M. T., Kazakov, A., Fries, P., Müller, A., Lenski, M., Custodis, F., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs218 · Cited by 130

Impact of social support, cynical hostility and anger expression on progression of coronary atherosclerosis

Angerer, P., Siebert, U., Kothny, W., Mühlbauer, D., Mudra, H. G., & von Schacky, C. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00944-x · Cited by 124

Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications*

Sander, O., Welters, I. D., Foëx, P., & Sear, J. W. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000150028.64264.14 · Cited by 124

Selective Heart Rate Reduction With Ivabradine Unloads the Left Ventricle in Heart Failure Patients

Reil, J., Tardif, J., Ford, I., Lloyd, S. M., O’Meara, E., Michel Komajda, N., BORER, J. S., Tavazzi, L., Swedberg, K. B., & Böhm, M. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.027 · Cited by 122

Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke

Böhm, M., Cotton, D., Foster, L. D., Custodis, F., Laufs, U., Sacco, R. L., Bath, P. M., Yusuf, S., & Diener, H. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs250 · Cited by 114

Resting Heart Rate in Middle Age and Diabetes Development in Older Age

Carnethon, M. R., Yan, L. L., Greenland, P., Garside, D. B., Dyer, A. R., Metzger, B. E., & Daviglus, M. L. (2008) · Diabetes Care · doi:10.2337/dc07-0874 · Cited by 114

Morphometric evidence for impairment of renal autoregulation in advanced essential hypertension

Hill, G. S., Heudes, D., Jacquot, C., Gauthier, É., & Bariety, J. (2006) · Kidney International · doi:10.1038/sj.ki.5000163 · Cited by 108

Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: An efficacy and safety analysis of SHIFT study

Tavazzi, L., Swedberg, K. B., Michel Komajda, N., Böhm, M., BORER, J. S., Lainščak, M., Robertson, M., & Ford, I. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.10.068 · Cited by 103

Low-grade albuminuria and cardiovascular risk

Schmieder, R. E., Schrader, J., Zidek, W., Tebbe, U., Paar, W. D., Bramlage, P., Pittrow, D., & Böhm, M. (2007) · Clinical Research in Cardiology · doi:10.1007/s00392-007-0510-3 · Cited by 101

Intravenous Rosuvastatin for Acute Stroke Treatment

Prinz, V., Laufs, U., Gertz, K. R., Kronenberg, G., Balkaya, M., Leithner, C., Lindauer, U., & Endres, M. (2007) · Stroke · doi:10.1161/strokeaha.107.492470 · Cited by 99

Systolic Blood Pressure Variation and Mean Heart Rate Is Associated With Cognitive Dysfunction in Patients With High Cardiovascular Risk

Böhm, M., Schumacher, H., Leong, D. P., Mancia, G., Unger, T., Schmieder, R. E., Custodis, F., Diener, H., Laufs, U., Lonn, E., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04568 · Cited by 98

Association of Resting Heart Rate With Carotid and Aortic Arterial Stiffness

Whelton, S. P., Blankstein, R., Al-Mallah, M. H., Lima, J. A. C., Bluemke, D. A., Hundley, W. G., Polak, J. F., Blumenthal, R. S., Nasir, K., & Blaha, M. J. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01605 · Cited by 98

Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials

Fox, K. M., Michel Komajda, N., Ford, I., Robertson, M., Böhm, M., BORER, J. S., Steg, P. G., Tavazzi, L., Tendera, M., Ferrari, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht101 · Cited by 95

Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice

Drouin, A., Gendron, M.-E., Thorin, É., Gillis, M., Mahlberg‐Gaudin, F., & Tardif, J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.116 · Cited by 94

Relationship between Heart Rate and Mortality and Morbidity in the Irbesartan Patients with Heart Failure and Preserved Systolic Function Trial (I-Preserve)

Böhm, M., Moreno, A. C. P., Jhund, P. S., Reil, J. C., Michel Komajda, N., Zile, M. R., McKelvie, R. S., Anand, I. S., Massie, B. M., Carson, P. E., et al. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.85 · Cited by 94

Heart rate correlates with severity of coronary atherosclerosis in young postinfarction patients

Perski, A., Hamsten, A., Lindvall, K., & Theorell, T. (1988) · American Heart Journal · doi:10.1016/0002-8703(88)90469-3 · Cited by 94

Heart rate: A global target for cardiovascular disease and therapy along the cardiovascular disease continuum

Custodis, F., Reil, J., Laufs, U., & Böhm, M. (2013) · Journal of Cardiology · doi:10.1016/j.jjcc.2013.02.018 · Cited by 91

All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy

Okin, P. M., Kjeldsen, S. E., Julius, S., Hille, D. A., Dahlöf, B., Edelman, J. M., & Devereux, R. B. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq225 · Cited by 90

Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure

Milliez, P., Messaoudi, S., Nehmé, J., Rodriguez, C., Samuel, J., & Delcayre, C. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00591.2008 · Cited by 88

Elevated Heart Rate: A “New” Cardiovascular Risk Factor?

Palatini, P. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.06.001 · Cited by 87

Heart Rate Contributes to the Vascular Effects of Chronic Mental Stress

Custodis, F., Gertz, K. R., Balkaya, M., Prinz, V., Mathar, I., Stamm, C., Kronenberg, G., Kazakov, A., Freichel, M., Böhm, M., et al. (2011) · Stroke · doi:10.1161/strokeaha.110.598607 · Cited by 82

Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study

Werdan, K., Ebelt, H., Nuding, S., Höpfner, F., Hack, G., & Müller‐Werdan, U. (2012) · Clinical Research in Cardiology · doi:10.1007/s00392-011-0402-4 · Cited by 79

Efficacy and Safety of Ivabradine in Chronic Heart Failure Across the Age Spectrum: Insights from the SHIFT Study

Tavazzi, L., Swedberg, K. B., Michel Komajda, N., Böhm, M., BORER, J. S., Lainščak, M., & Ford, I. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft102 · Cited by 78

Preservation of coronary reserve by ivabradine-induced reduction in heart rate in infarcted rats is associated with decrease in perivascular collagen

Dedkov, E. I., Zheng, W., Christensen, L. P., Weiss, R. M., Mahlberg‐Gaudin, F., & Tomanek, R. J. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00047.2007 · Cited by 77

Resting Heart Rate and Incident Heart Failure and Cardiovascular Mortality in Older Adults: Role of Inflammation and Endothelial Dysfunction: The PROSPER Study

Nanchen, D., Stott, D. J., Gussekloo, J., Mooijaart, S. P., Westendorp, R. G. J., Jukema, J. W., Macfarlane, P. W., Cornuz, J., Rodondi, N., Buckley, B. M., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs195 · Cited by 75

Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH

Böhm, M., Reil, J., Danchin, N., Thoenes, M., Bramlage, P., & Volpe, M. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f05c8a · Cited by 73

Erectile dysfunction correlates with left ventricular function and precedes cardiovascular events in cardiovascular high-risk patients

Baumhäkel, M., & Böhm, M. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01274.x · Cited by 72

Role of Heart Rate Reduction in the Prevention of Experimental Heart Failure

Becher, P. M., Lindner, D., Miteva, K., Savvatis, K., Zietsch, C., Schmack, B., Linthout, S. V., Westermann, D., Schultheiss, H., & Tschöpe, C. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.183913 · Cited by 71

Heart-rate reduction by If-channel inhibition with ivabradine restores collateral artery growth in hypercholesterolemic atherosclerosis

Schirmer, S. H., Degen, A., Baumhäkel, M., Custodis, F., Schuh, L. K., Kohlhaas, M., Friedrich, E. B., Bahlmann, F. H., Kappl, R., Maack, C., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr255 · Cited by 71

Resting Heart Rate and the Risk of Microvascular Complications in Patients With Type 2 Diabetes Mellitus

Hillis, G. S., Hata, J., Woodward, M., Perkovic, V., Arima, H., Chow, C. K., Zoungas, S., Patel, A. A., Poulter, N. R., Mancia, G., et al. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.002832 · Cited by 68

Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study

Hoke, R. S., Müller‐Werdan, U., Lautenschläger, C., Werdan, K., & Ebelt, H. (2011) · Clinical Research in Cardiology · doi:10.1007/s00392-011-0375-3 · Cited by 66

Force-frequency relationship and inotropic stimulation in the nonfailing and failing human myocardium: implications for the medical treatment of heart failure

B�hm, M., Ros�e, K., Schmidt, U. H., Schulz, C., Schwinger, R. H. G., & Erdmann, E. (1992) · Journal of Molecular Medicine · doi:10.1007/bf00235525 · Cited by 62

Ultimate survival from septic shock

Azimi, G., & Vincent, J. (1986) · Resuscitation · doi:10.1016/0300-9572(86)90068-7 · Cited by 61

Severity of cardiac impairment in the early stage of community-acquired sepsis determines worse prognosis

Wilhelm, J., Hettwer, S., Schuermann, M., Bagger, S., Gerhardt, F., Mundt, S., Muschik, S., Zimmermann, J., Bubel, S., Amoury, M., et al. (2013) · Clinical Research in Cardiology · doi:10.1007/s00392-013-0584-z · Cited by 58

The Effect of Heart Rate Reduction with Ivabradine on Renal Function in Patients with Chronic Heart Failure: An Analysis from SHIFT

Voors, A. A., van Veldhuisen, D. J., Robertson, M., Ford, I., BORER, J. S., Böhm, M., Michel Komajda, N., Swedberg, K. B., & Tavazzi, L. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.59 · Cited by 57

Beta-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease

Simon, E. (2013) · ScholarWorks -A service of University of Vermont Libraries (University of Vermont) · Cited by 57

Relation of Resting Heart Rate to Prognosis in Patients With Idiopathic Pulmonary Arterial Hypertension

Henkens, I. R., van Wolferen, S. A., Gan, C. T., Boonstra, A., Swenne, C. A., Twisk, J. W. R., Otto Kamp, B., van der Wall, E. E., Schalij, M. J., Noordegraaf, A. V., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.01.359 · Cited by 53

Efficacy and Safety of Ivabradine in Patients With Severe Chronic Systolic Heart Failure (from the SHIFT Study)

BORER, J. S., Böhm, M., Ford, I., Robertson, M., Michel Komajda, N., Tavazzi, L., & Swedberg, K. B. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.10.033 · Cited by 51

Evidence of a synergistic association between heart rate, inflammation, and cardiovascular mortality in patients undergoing coronary angiography

Hartaigh, B. Ó., Bosch, J. A., Carroll, D., Hemming, K., Pilz, S., Loerbroks, A., Kleber, M. E., Grammer, T. B., Fischer, J. E., Boehm, B. O., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs396 · Cited by 50

Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies

Böhm, M., Schumacher, H., Schmieder, R. E., Mann, J. F. E., Teo, K. K., Lonn, E., Sleight, P., Mancia, G., Linz, D., Mahfoud, F., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12333 · Cited by 48

Elevated troponin in septic patients in the emergency department: frequency, causes, and prognostic implications

Wilhelm, J., Hettwer, S., Schuermann, M., Bagger, S., Gerhardt, F., Mundt, S., Muschik, S., Zimmermann, J., Amoury, M., Ebelt, H., et al. (2014) · Clinical Research in Cardiology · doi:10.1007/s00392-014-0684-4 · Cited by 47

Risk Following Hospitalization in Stable Chronic Systolic Heart Failure

Abrahamsson, P., Swedberg, K. B., BORER, J. S., Böhm, M., Køber, L., Michel Komajda, N., Lloyd, S. M., Metra, M., Tavazzi, L., & Ford, I. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft032 · Cited by 47

Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I f (funny channel current) inhibitor ivabradine

Nuding, S., Ebelt, H., Hoke, R. S., Krummenerl, A., Wienke, A., Müller‐Werdan, U., & Werdan, K. (2011) · Clinical Research in Cardiology · doi:10.1007/s00392-011-0323-2 · Cited by 47

Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice

Baumhäkel, M., Custodis, F., Schlimmer, N., Laufs, U., & Böhm, M. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.03.002 · Cited by 43

Morbidity and Mortality in Cardiovascular Disorders: Impact of Reduced Heart Rate

Singh, B. N. (2001) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840100600401 · Cited by 41

Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients

Böhm, M., Thoenes, M., Neuberger, H., Gräber, S., Reil, J., Bramlage, P., & Volpe, M. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp124 · Cited by 41

Optimization of pharmacotherapy in chronic heart failure: is heart rate adequately addressed?

Franke, J., Wolter, J. S., Meme, L., Keppler, J., Tschierschke, R., Katus, H. A., & Zugck, C. (2012) · Clinical Research in Cardiology · doi:10.1007/s00392-012-0489-2 · Cited by 37

Endurance Exercise Training Improves Heart Rate Recovery in Patients with COPD

Gimeno‐Santos, E., Rodriguez, D. A., Barberán-García, A., Blanco, I., Vilaró, J., Torralba, Y., Rodriguez‐Roisin, R., Barberà, J. A., Roca, J., & García‐Aymerich, J. (2013) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2013.831401 · Cited by 33

BEAUTIFUL results—the slower, the better?

Reil, J., & Böhm, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61172-1 · Cited by 32

Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure

Link, A., Reil, J. C., Selejan, S., & Böhm, M. (2009) · Clinical Research in Cardiology · doi:10.1007/s00392-009-0038-9 · Cited by 29

Impact of Left Bundle Branch Block on Heart Rate and its Relationship to Treatment with Ivabradine in Chronic Heart Failure

Reil, J., Robertson, M., Ford, I., BORER, J. S., Michel Komajda, N., Swedberg, K. B., Tavazzi, L., & Böhm, M. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft072 · Cited by 28

Differential effects of heart rate reduction by atenolol or ivabradine on peripheral endothelial function in type 2 diabetic patients

Nerla, R., Franco, A. D., Milo, M., Pitocco, D., Zaccardi, F., Tarzia, P., Sarullo, F. M., Villano, A., Russo, G., Stazi, A., et al. (2012) · Heart · doi:10.1136/heartjnl-2012-302795 · Cited by 28

Heart Rate per se Impacts Cardiac Function in Patients with Systolic Heart Failure and Pacing: A Pilot Study

Logeart, D., Gueffet, J.-P., Rouzet, F., Pousset, F., Chavelas, C., Solal, A. C., & Jondeau, G. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn016 · Cited by 26

Heart rate differentiates urgency and emergency in hypertensive crisis

Bannay, R. A., Böhm, M., & Husain, A. (2013) · Clinical Research in Cardiology · doi:10.1007/s00392-013-0570-5 · Cited by 26

Heart rate: surrogate or target in the management of heart failure?

Böhm, M., & Reil, J. C. (2012) · Heart · doi:10.1136/heartjnl-2012-302301 · Cited by 26

Cardiopulmonary Rehabilitation Enhances Heart Rate Recovery in Patients With COPD

Georgiopoulou, V. V., Dimopoulos, S. K., Sakellariou, D., Papazachou, O., Gerovasili, V., Tasoulis, A., Agapitou, V., Vogiatzis, I., Roussos, C., & Nanas, S. (2012) · Respiratory Care · doi:10.4187/respcare.01485 · Cited by 20

Ivabradine: potential clinical applications in critically ill patients

Santis, V. D., Vitale, D., Santoro, A., Magliocca, A., Porto, A. G., Nencini, C., & Tritapepe, L. (2012) · Clinical Research in Cardiology · doi:10.1007/s00392-012-0516-3 · Cited by 19

Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patients

Kratz, M. T., Schumacher, H., Sliwa, K. S., Schmieder, R. E., Pöss, J., Mahfoud, F., Unger, T., Lonn, E., Koon, T., Mancia, G., et al. (2013) · European Journal of Preventive Cardiology · doi:10.1177/2047487313494835 · Cited by 15

Safe and well-tolerated treatment with ivabradine in systemic sclerosis affected by pulmonary hypertension

Correale, M., Montrone, D., Biase, M. D., & Brunetti, N. D. (2012) · Clinical Research in Cardiology · doi:10.1007/s00392-012-0437-1 · Cited by 9

Ivabradine therapy to unmask heart rate-independent effects of β-blockers on pulse wave reflections

Fischer‐Rasokat, U., Honold, J., Lochmann, D., Liebetrau, C., Leick, J., Hamm, C. W., Fichtlscherer, S., Möllmann, H., & Spyridopoulos, I. (2014) · Clinical Research in Cardiology · doi:10.1007/s00392-014-0679-1 · Cited by 9

Ivabradine in pulmonary arterial hypertension: can we delay the need for parenteral prostanoid therapy?

Correale, M., Montrone, D., Ieva, R., Biase, M. D., & Brunetti, N. D. (2013) · Clinical Research in Cardiology · doi:10.1007/s00392-013-0541-x · Cited by 6

Untitled work

Filippatos, T. D., Panagiotopoulou, T. V., & Elisaf, M. S. (2014) · The Review of Diabetic Studies · Cited by 560

Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined

Lundgren, J. R., Janus, C., Jensen, S. B. K., Juhl, C. R., Olsen, L. M., Christensen, R. M., Svane, M. S., Bandholm, T., Bojsen-Møller, K. N., Blond, M. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2028198 · Cited by 536

Resting heart rate and all-cause and cardiovascular mortality in the general population: a meta-analysis

Zhang, D., Shen, X., & Qi, X. (2015) · Canadian Medical Association Journal · doi:10.1503/cmaj.150535 · Cited by 329

Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank: A Mendelian Randomization Study

Lyall, D. M., Celis-Morales, C., Ward, J., Iliodromiti, S., Anderson, J. J., Gill, J. M. R., Smith, D. J., Ntuk, U. E., Mackay, D. F., Holmes, M. V., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2016.5804 · Cited by 235

Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

Lip, G. Y. H., Coca, A., Kahan, T., Boriani, G., Manolis, A. S., Olsen, M. H., Oto, A., Potpara, T., Steffel, J., Marín, F. R., et al. (2017) · EP Europace · doi:10.1093/europace/eux091 · Cited by 233

Heart rate and heart failure

Reil, J., & Böhm, M. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32836043af · Cited by 8

Current status: heart rate as a treatable risk factor

Fox, K. M. (2011) · European Heart Journal Supplements · doi:10.1093/eurheartj/sur016 · Cited by 8

Heart Rate and its Reduction in Chronic Heart Failure and Beyond

Vukadinović, A. N., Vukadinović, D., BORER, J. S., Cowie, M., Michel Komajda, N., Lainščak, M., Swedberg, K. B., & Böhm, M. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.902 · Cited by 51

[The resting heart rate].

Bemelmans, R. H. H., & Visseren, F. L. J. (2014) · PubMed · Cited by 1

The importance of heart rate control in the management of heart failure

Custodis, F., Reil, J. C., Laufs, U., & Böhm, M. (2010)